Select Page

Infection

Home » Infections

Clinical Trial Characteristics of Infectious Diseases

In this competitive field, that is affected by medical insurance coverage and a low number of potential patients for initial treatment, high-quality clinical trials are a must. There is an abundance of clinical trials in this very competitive field, resulting in difficulty in finding patients. Requirements for biological sample management are high, treatment and follow-up periods are long, and it is often difficult to manage extended follow-up duration.

 

Advantages of Tigermed

*As of Q1 2020

Tigermed has nearly 20 years of rich project management experience in the field of hepatitis, and has participated in many clinical studies of 1.1 new drug products, and obtained the approval from CDE. We have established good cooperative relationship with infectious disease experts in major hospitals, and cooperated with 90% of clinical research centers in China through a large number of clinical studies (including large-scale post-market researches).

 

Project Experience

*As of Q1 2020

The infectious product team is managed by 4 project directors and 6 project managers who have an average working experience of 10 years. To facilitate disease management, Tigermed has one of the few internet platforms featuring liver disease management in Chinato assist doctors in their scientific research, patient follow-up, efficacy tracking, medical record analysis, and other related services, providing medical professionals with a wide range of detailed clinical data tools for clinical decision-making.

Representative products include:

  • Shield–a hepatitis B mother and child block management app
  • Achronic hepatitis B follow-up data entry platform
  • Dr. Zhi Lan docture– chronic hepatitis B patients follow-up registration management platform

Whether it is experts from the top tier hospitals or local community, these products meet their individual needs in personalized research and follow-up management. By combining the advantages of various information sources, we are currently implementing multidisciplinary team consultations to provide sophisticated high-quality medical services for patients affected by liver disease.

Our clinical trial experience includes but is not limited to the following Infectious Disease indications:

  • Liver protection
  • Hepatitis C
  • Hepatitis B
  • Non-alcoholic fatty liver
  • Liver fibrosis
  • Severe liver disease